Proven Track Record of GMP Batches
Our mammalian facility boasts a 500m2
GMP area, and with more than 100 dedicated engineers and technicians, we are able to offer unparalleled expertise in every area of your manufacturing process. From 2012 to the present, we have produced:
- MAbs: Over 129 GMP batches manufactured - 50 L to 2000 L
- Fc-fusion: Over 50 GMP batches manufactured - 50 L to 2000 L
- Fab: Over 3 GMP batches manufactured - 50 L to 2000 L
- Recombinant proteins: Over 129 GMP batches manufactured - 50 L to 2000 L
High Quality Standards
At our Biodevelopment Center in Martillac, FR, we use state-of-the-art technologies across three Upstream Suites with 2K Liter Single-Use Bioreactors and two fully Single-use Downstream Suites.
Our GMP manufacturing production facilities are approved by the French Health Authority (ANSM) for cGMP related activities.
Additionally, our facility has been audited by:
- US FDA
- Japanese authority
- Australian authority
360° Tour: State-of-the-Art GMP Bioproduction
Tour our Martillac, France facility. The site serves our BioReliance® biodevelopment and clinical supply solutions, an innovative, "open source" manufacturing option that incorporates the latest technologies for upstream and downstream processes.
Take the Tour
Open Source Manufacturing
Unlike other contract Manufacturing Organizations (CMO), with our Biodevelopment Center, you have access to state of the art GMP production capabilities with the full freedom and transparency needed to define your upcoming production strategy.
- No royalties
- No benchmark fees
Freedom to Transfer Your Process Anytime, Anywhere
When the time comes to move to manufacturing scale production, we will help you transfer it to a local manufacturing partner for routine production, or move it and build your own facility, we will work with you to ease the process and make your program a success. Learn more about our Tech Transfer Services.
Guidebook: A Molecule's Journey - Break Down Roadblocks To Clinical Success
The key to this success is to make the right decisions at the right time. In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.
Case Study: Building a Fully Single-Use GMP Biomanufacturing Facility in Martillac, France
In 2011, we converted a stainless steel good manufacturing practice (GMP) bioproduction facility in Martillac, France into a state-of-the-art, fully single-use GMP facility, providing clients with increased speed to clinic. In this case study, we share with you some critical success factors and lessons learned.
|Brochure: Your Partner To Speed From DNA To Market
|Brochure: Plug & Play Upstream Development Service
A service exactly tailored to small-sized biotechs and start-ups, needing to balance cost and speed to clinic while getting it right the first time.Download Brochure